Acorda Therapeutics Inc (NASDAQ:ACOR)

Delayed Data
As of Mar 16
 +1.00 / +4.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 15.00. The median estimate represents a -20.16% decrease from the last price of 25.05.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.16%
Growthannually -90.06%


Growthquarterly -29.86%
Growthannually -36.80%
Key to the earnings and sales forecast charts.